Skip to content

Clinical trials

Phase 3 Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 3 Country / region: United States Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20034
20041
20052
20065
20082
20092
20102
20112
20121
20147
20152
20161
20172
20181
20192
20201
20212
20221
20232
20242
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting7
Terminated5
Active, not recruiting4
Withdrawn2
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Genentech, Inc.3
Virginia Commonwealth University3
89bio, Inc.2
AbbVie2
GlaxoSmithKline2
InterMune2
Janssen Infectious Diseases BVBA2
Madrigal Pharmaceuticals, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis53
Hepatitis C12
Liver Diseases10
Non-alcoholic Fatty Liver Disease10
Fatty Liver5
Hypertension, Portal5
Idiopathic Pulmonary Fibrosis5
Liver Cirrhosis5
Esophageal and Gastric Varices4
Hepatitis C, Chronic4

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.